Physician

Adam Fleischer, D.P.M.

According to 2025 Medicare claims, Adam Fleischer, D.P.M. (NPI: 1932111606) practices podiatry in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is WEIL FOOT AND ANKLE INSTITUTE LLC (NPI: 1710965314; TIN: 363481646) and primary practice location at 60657-6456. Fleischer is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Fleischer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 92 traditional Medicare patients, billed 768 HCPCS/CPT codes, and received $159,722 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 110 prescription claims across 52 beneficiaries totaling $3,129 in drug costs, led by Pentoxifylline (Pentoxifylline). 2019 DME data shows 16 claims. Open Payments data shows 19 records totaling $1,667. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $22,452 to $159,722. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,715 and ending at $3,129. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $5,954 and ending at $5,837.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	104	400	$22,452
2016	115	394	$24,407
2017	112	514	$31,186
2018	122	468	$28,898
2019	139	603	$37,159
2020	137	556	$30,743
2021	114	624	$48,467
2022	132	1,014	$85,016
2023	101	741	$66,550
2024	92	768	$159,722

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	40	$5,715
2016	37	69	$1,341
2017	52	128	$2,616
2018	45	83	$2,052
2019	62	132	$15,606
2020	46	146	$15,859
2021	41	121	$2,480
2022	56	151	$3,611
2023	46	131	$2,875
2024	52	110	$3,129

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	15	16	$1,722
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	22	48	$97
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	26	26	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	41	106	$71
99202	New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more	13	13	$47
73630	X-ray of foot, minimum of 3 views	22	43	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pentoxifylline	Pentoxifylline	19	596	$478
Terbinafine Hcl	Terbinafine Hcl	20	700	$200
Levofloxacin	Levofloxacin	12	213	$157
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	182	$156

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$1,667	Endo Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Fleischer, D.P.M.?

Tedicare shows public-source Medicare data for Adam Fleischer, D.P.M. (NPI 1932111606), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Fleischer, D.P.M. have ACO affiliation data?

Adam Fleischer, D.P.M. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Adam Fleischer, D.P.M.?

Adam Fleischer, D.P.M. is linked to WEIL FOOT AND ANKLE INSTITUTE LLC (billing NPI 1710965314) in the available physician profile data.

Does Adam Fleischer, D.P.M. have Open Payments data?

Adam Fleischer, D.P.M. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.